Front. Mol. Biosci. Frontiers in Molecular Biosciences Front. Mol. Biosci. 2296-889X Frontiers Media S.A. 727969 10.3389/fmolb.2021.727969 Molecular Biosciences Correction Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib Zhang et al. Corrigendum: NLR and PLR in HCC Zhang Lei 1 † Yan Zhi-Ping 2 3 4 † Hou Zhong-Heng 1 † Huang Peng 1 † Yang Min-Jie 2 3 4 Zhang Shuai 1 Zhang Shen 1 Zhang Shao-Hua 5 Zhu Xiao-Li 1 ‡ Ni Cai-Fang 1 ‡ Li Qiang 6 * ‡ Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China Shanghai Institution of Medical Imaging, Shanghai, China National Clinical Research Center for Interventional Medicine, Shanghai, China Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen, China Department of Radiology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Qiang Li, rmliqiang@nbu.edu.cn

These authors have contributed equally to this work and share first authorship

These authors have contributed equally

This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences

 30 08 2021 2021 8 727969 20 06 2021 30 07 2021 Copyright © 2021 Zhang, Yan, Hou, Huang, Yang, Zhang, Zhang, Zhang, Zhu, Ni and Li. 2021 Zhang, Yan, Hou, Huang, Yang, Zhang, Zhang, Zhang, Zhu, Ni and Li

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum onNeutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib by Zhang, L., Yan, Z.-P., Hou, Z.-H., Huang, P., Yang, M.-J., Zhang, S., Zhang, S., Zhang, S.-H., Zhu, X.-L., Ni, C.-F., and, Li, Q (2021). Front. Mol. Biosci. 8:624366. doi: 10.3389/fmolb.2021.624366 TACE sorafenib HCC platelet count neutrophils lymphocytes

In the published article, there was an error regarding the affiliations for Lei Zhang and Cai-Fang Ni. One of the affiliations was added in error. This has now been removed.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.